Increased intestinal permeability in patients with Crohn's disease and their first degree relatives has been proposed as an aetiological factor. The nine hour overnight urinary excretion of polyethyleneglycol-400 (PEG-400) and three inert sugars (lactulose, I-rhamnose, and mannitol) was used to test the permeation in 47 patients with Crohn's disease of whom 18 had at least one first degree relative with inflammatory bowel disease (2BD) and 52 patients with ulcerative colitis of whom 16 had at least one first degree relative with IBD. A total of 17 first degree relatives with IBD and 56 healthy first degree relatives were included. Thirty one healthy subjects not related to patients with IBD served as controls. No significant differences in PEG-400 permeation were found between the groups of patients, relatives, and controls, or between diseased and healthy relatives. The permeability to lactulose, rhamnose, and mannitol similarly did not differ between the three groups. This study challenges the previously reported findings of increased PEG-400 permeation in patients with Crohn's disease and in their healthy and diseased first degree relatives. There was no increase in permeability in a similar group of ulcerative colitis patients and their families. (Gut 1994; 35: 68-72) 
There has been great interest in the hypothesis of increased intestinal permeability as a pathogenetic factor in Crohn's disease. Evidence has been found for a genetic predisposition to Crohn's disease.' A 10-fold increased risk of inflammatory bowel disease among first degree relatives of patients with ulcerative colitis and Crohn's disease has recently been found in a regional epidemiological study.4 Therefore further permeability studies of healthy and diseased relatives of inflammatory bowel disease patients were needed to clarify the possible connection between permeability abnormalities and genetic predisposition to inflammatory bowel disease.
Excretion of the hydrofilic polyethyleneglycol-400 (PEG-400) in urine after oral ingestion has been suggested as a possible marker of a genetically determined increased permeability of the gut wall. An increase in PEG-400 permeation in Crohn's disease patients and their first degree healthy relatives compared with healthy controls was found in a previous study,5 whereas two other studies could not confirm these findings.67 Absorption of inert sugars such as lactulose (L), rhamnose (R), and mannitol (M) was subsequently tested by Hollander's group and permeability abnormalities could not be found in the relatives but patients with inflammatory bowel diseases had increased lactulose permeation compared with the control group.8 Two studies have recently shown, however, increased L/M ratio in first degree healthy relatives compared with Crohn's disease patients.9 '0 The aims of this study have been firstly, to elucidate whether previously reported results of increased permeability in Crohn's disease patients and their healthy relatives could be confirmed in a larger group ofpatients; secondly, to extend the permeability analysis to inflammatory bowel disease patients with known familial occurrence and their diseased and healthy first degree relatives to evaluate possible differences in absorption ofthe PEG-400 and the three insert sugars, lactulose, rhamnose, and mannitol in these families.
Patients and methods

SELECTION OF THE PATIENTS
Patients with known familial occurrence of inflammatory bowel disease were included in the study, and encouraged to contact all their first degree relatives and propose their participation in the study. Other patients were included consecutively from the outpatient clinic in Copenhagen County.
All patients had stopped taking non-steroidal anti-inflammatory drugs (NSAIDs) for more than 30 days. Seven patients on topical steroids and six on low dose systemic steroids were included. Twenty five Crohn's disease patients and 25 ulcerative colitis patients were receiving maintenance treatment with sulphasalazine or 5-aminosalicylic acid (5-ASA).
The Crohn's disease activity index" and activity score of ulcerative colitis,'2 the extent of the disease at diagnosis, age, sex, duration of disease, and length of resection were recorded. Active Crohn's disease was considered when the index was >150 and active ulcerative colitis was considered when scoring was >II.
Crohn's disease Forty seven patients with Crohn's disease were included, F/M: 30/17, median age: 38 years . The median duration of disease was six years (1-37).
Twenty nine of the patients had had a previous operation, with a median resection length of 55 cm (10- PEG/rhamnose 2-6 3-1 2-3 2-9 2-6 2-9
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(1*7-18-8) ever, a slightly positive correlation between the activity of the disease and the permeation of lactulose-mannitol ratio (Fig 2) .
In conclusion, the previously reported results of increased PEG-400 permeation in Crohn's disease patients and their first degree healthy relatives could not be confirmed because even in families with clustering of inflammatory bowel disease patients no increase in permeation could be shown. Thus the hypothesis of a 'genetic leakiness' of the intestine was not confirmed. 
